Peer Effects in Workplace Health

Last registered on September 10, 2021

Pre-Trial

Trial Information

General Information

Title
Peer Effects in Workplace Health
RCT ID
AEARCTR-0008209
Initial registration date
September 08, 2021
Last updated
September 10, 2021, 12:23 PM EDT

Locations

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information

Primary Investigator

Affiliation

Other Primary Investigator(s)

Additional Trial Information

Status
On going
Start date
2021-01-01
End date
2022-12-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
There exists a large literature studying peer effects in economics yet little research on how peer effects in health can occur in the workplace. This experiments aims to derive causal estimate of workplace peer effects and to study the underlying mechanisms. The setting is a large company in the US and the context is the fall vaccination campaign.
External Link(s)

Registration Citation

Citation
Barankay, Iwan. 2021. "Peer Effects in Workplace Health." AEA RCT Registry. September 10. https://doi.org/10.1257/rct.8209-1.0
Experimental Details

Interventions

Intervention(s)
The interventions are happening in the context of a yearly flu vaccine drive. There will be two set of interventions.
In interventions (A) we split all employees who did not opt out of communications into three groups. The first group is receives the standard message, comparable to how it was used in prior years at the company. The second group receives a message that tells them that taking vaccinations will inspire others to do the same, a passive peer effect. The third group receives a message that encourages them to get other people to get vaccinated, an active peer effect.
Concurrently we randomly select 200 people at the firm who are told that if they get vaccinated before a deadline $100 will be donated to a charity.
Intervention Start Date
2021-09-15
Intervention End Date
2021-10-15

Primary Outcomes

Primary Outcomes (end points)
Primary outcome is individual level flu vaccination status (binary).
Primary Outcomes (explanation)
This variable is drawn from the company wellness program that is linked to employees health records.

Secondary Outcomes

Secondary Outcomes (end points)
Company wellness program points, LDL, Blood pressure, glucose level, ASCVD risk, medical expenses without Rx, Rx medical expenses, attrition. Sub-population analysis by race, ethinicity, job tenure, and social preferences
Secondary Outcomes (explanation)
company wellness program points, LDL, blood pressure, glucose level, ASCVD risk, medical expenses with and without Rx are derived from the companies wellness program that is linked with health records. Attrition, race, ethnicity and job tenure is based on HR data. Social preferences is based on measure from online experiments conducted during the second half of 2020.

Experimental Design

Experimental Design
Part A. Employees at the company are randomized into four groups and receive different messages encouraging them to get a flu vaccine.
This tests whether being informed of peer effects (group 2) or being encouraged to influence others (group 3) affects the flu vaccination rate compared to the control group.
Part B. 200 randomly selected employees receive a message telling them that when vaccinated an amount will be donated to a charity. The outcome of interest is the flu vaccination rate of the peers of the recepient of the message compared to those employees where the peers did not receive a message.
Experimental Design Details
Not available
Randomization Method
Part A: Ranomization with Stata's runiform routine that allocates a number of 0, 1, or 2 to each employee at the company thus allocating them to the control message, the second group or the third group.
Part B: independently from the randomization in part A 200 employees are drawn using SAS's survey select routine stratified by age, company wellness program status level, and hierarchy tier in the company.
Randomization Unit
Randomization is at the individual level.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
28793
Sample size: planned number of observations
28793
Sample size (or number of clusters) by treatment arms
Part A: Control (7,198), First group (7,198), Second Group (7,198), Third group (7,199)
Part B: Treatment (200)
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Measurable vaccination rate is 0.56 in the control arm. This is based on flu shot vaccination rates from the past year. With a power of 0.8 the minimum detectable effect (delta) will be an increase of 2.39 percentage points (0.5839 - 0.56) With a power of 0.9 the minimum detectable effect will be an increase of 2.71 percentage points (0.5871 - 0.56)
IRB

Institutional Review Boards (IRBs)

IRB Name
University of Pennsylania
IRB Approval Date
2021-09-08
IRB Approval Number
843142